107 related articles for article (PubMed ID: 3298856)
21. Abbott phencyclidine and barbiturates abused drug assays: evaluation and comparison of ADx FPIA, TDx FPIA, EMIT, and GC/MS methods.
Caplan YH; Levine B
J Anal Toxicol; 1989; 13(5):289-92. PubMed ID: 2693834
[TBL] [Abstract][Full Text] [Related]
22. Urinary screening for alpha-OH triazolam by FPIA and EIA with confirmation by GC/MS.
Fraser AD; Bryan W; Isner AF
J Anal Toxicol; 1992; 16(6):347-50. PubMed ID: 1293398
[TBL] [Abstract][Full Text] [Related]
23. Comparison of three immunoassays for the determination of N-acetylprocainamide. Determination of false elevations by a polyclonal antibody-based method.
Laurino JP; McKay J; Fischberg E; Schwenzer K; Kaufman R
Ther Drug Monit; 1994 Jun; 16(3):312-5. PubMed ID: 7521980
[TBL] [Abstract][Full Text] [Related]
24. Determination of serum theophylline by apoenzyme reactivation immunoassay system.
Plebani M; Burlina A
Ther Drug Monit; 1985; 7(4):451-4. PubMed ID: 3909537
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of two methods for therapeutic drug monitoring: FPIA (TDx) and Emit].
Bogovskiĭ BP; Barmanova EIu
Vopr Med Khim; 1991; 37(3):80-2. PubMed ID: 1949699
[TBL] [Abstract][Full Text] [Related]
26. Urinary screening for midazolam and its major metabolites with the Abbott ADx and TDx analyzers and the EMIT d.a.u. benzodiazepine assay with confirmation by GC/MS.
Fraser AD; Bryan W; Isner AF
J Anal Toxicol; 1991; 15(1):8-12. PubMed ID: 2046344
[TBL] [Abstract][Full Text] [Related]
27. [Determining the methotrexate concentration in serum with the fluorescence polarization immunoassay (FPIA)--a comparison with the enzyme immunoassay (EMIT)].
Liappis N
Klin Padiatr; 1986; 198(1):33-6. PubMed ID: 3515034
[TBL] [Abstract][Full Text] [Related]
28. [Blood lidocaine concentration--comparison between enzyme- immunoassay and high pressure liquid chromatography].
Ogawa H; Inaba M; Horio M; Yurino M
Masui; 1984 Jan; 33(1):50-5. PubMed ID: 6371284
[No Abstract] [Full Text] [Related]
29. Particle counting immunoassay for urinary cotinine. Comparison with chromatography, enzyme-linked immunoassay and fluorescence polarization immunoassay.
Galanti LM; Dell'Omo J; Vanbeckbergen D; Dubois P; Masson PL; Cambiaso CL
Clin Chem Lab Med; 1999 Jul; 37(7):729-34. PubMed ID: 10510730
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of antiepileptic drugs by gas chromatography using capillary or packed columns and by fluorescence polarization immunoassay.
Chen K; Khayam-Bashi H
J Anal Toxicol; 1991; 15(2):82-5. PubMed ID: 2051749
[TBL] [Abstract][Full Text] [Related]
31. Analysis of lidocaine on the COBAS INTEGRA.
Liu-Allison LY; Hui RA; Schwenzer KS
Ann Clin Lab Sci; 1997; 27(2):105-15. PubMed ID: 9098509
[TBL] [Abstract][Full Text] [Related]
32. Application of the Abbott TDx lidocaine, phenytoin, and phenobarbital assays to postmortem blood specimens.
Caplan YH; Levine B
J Anal Toxicol; 1988; 12(5):265-7. PubMed ID: 3066993
[TBL] [Abstract][Full Text] [Related]
33. Enzyme immunoassay for serum lidocaine in antiarrhythmic therapy.
Lehane DP; Wissert PJ; Menyharth P; Levy AL; Kukucka MA
Clin Chem; 1979 Apr; 25(4):614-6. PubMed ID: 380841
[TBL] [Abstract][Full Text] [Related]
34. [Determination of theophylline, phenobarbital and valproic acid by chromatographic and immunologic technics. Comparison of methods].
Vinçon G; Demotes-Mainard F; Bistue C; Jarry C; Brachet-Liermain A; Albin H
Ann Biol Clin (Paris); 1984; 42(6):427-32. PubMed ID: 6442547
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Abbott TDx for determination of phenobarbital in forensic blood specimens.
Marker EK; Krasselt WG; Mueggler PA
J Anal Toxicol; 1987; 11(6):257-9. PubMed ID: 3431094
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of i-PiT, TDX and EMIT measurement of serum phenytoin and digoxin levels].
Koizumi F; Kumai M; Ishimori A
Rinsho Byori; 1985 Jul; 33(7):761-70. PubMed ID: 3906186
[No Abstract] [Full Text] [Related]
37. The Abbott TDx fluorescence polarization immunoassay and liquid chromatography compared for five anticonvulsant drugs in serum.
Wang ST; Peter F
Clin Chem; 1985 Mar; 31(3):493-4. PubMed ID: 3971578
[No Abstract] [Full Text] [Related]
38. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
Sedman AJ; Molitoris BA; Nakata LM; Gal J
Am J Nephrol; 1986; 6(2):132-4. PubMed ID: 3085501
[TBL] [Abstract][Full Text] [Related]
39. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.
Kunsman GW; Manno JE; Cockerham KR; Manno BR
J Anal Toxicol; 1990; 14(3):149-53. PubMed ID: 1973747
[TBL] [Abstract][Full Text] [Related]
40. Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: its detection in sera of renally impaired patients.
Anne L; Hu M; Chan K; Colin L; Gottwald K
Ther Drug Monit; 1989 Sep; 11(5):585-91. PubMed ID: 2683253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
